Edmund T Y Lee, PhD. MBA.
MIoD. EurProBiol. CBiol. FIBiol. FCMI. FRSA

Dr Lee received his B.Sc and Ph.D in Microbiology at King's College, University of London. His Ph.D was financed by an Overseas Research Award and supervised by late Professors S. John Pirt and Michael Bazin in 1990.

Before his return to Hong Kong, Dr Lee was Group Leader at British Biotech Pharmaceuticals (now Vernalis after the merge of British Biotech and Vernalis Group) and Group Manager at Medeva Pharma (now acquired by Celltech). He specialised in fermentation, cell culture-based bioprocess and clinical trial manufacture. Dr Lee was involved in numerous recombinant DNA projects, spanning vaccines, chemokines and antithrombotics and, in various stages of development from CTX, IND through Phase III to pre-market regulatory inspection. Having participated also in a series of infrastructural projects, Dr Lee is well versed in technology transfer, cGMP, pilot facility operations and quality related and regulatory disciplines. He was awarded a full company sponsorship from British Biotech Pharmaceuticals and obtained his Master of Business Administration (MBA) from Warwick Business School.

In late-1999, Dr Lee joined the new Innovation and Technology Commission (formerly the Industry Department) of the Hong Kong Special Administrative Region Government as Senior Biotechnology Officer, advising the Commissioner for Innovation and Technology on strategic matters related to the development of biotechnology and Chinese medicine. He also served as Secretary of the Biotechnology and Environment Projects Vetting Committees. Dr Lee has championed two new funding solicitation themes on “Applied Genomics" and “Biosensor Technologies", setting directions for the biotechnology and biomedical development in Hong Kong.

Since October 2001, Dr Lee heads the Hong Kong Jockey Club Institute of Chinese Medicine Limited as Executive Director and serves as Convener of the Strategic Advisory Panel. He is also member of the Chinese Medicine Working Party of the Mainland-Hong Kong Technology Collaboration Committee set up between the Mainland and HKSAR Governments. Formerly, he was member of the Government's Admission of Talents Scheme and Biotechnology Projects Vetting Committee. Dr Lee currently holds the European Professional Biologist and Chartered Biologist status. He is a Fellow of the Royal Society of Arts, Institute of Biology and the Chartered Management Institute in the UK, and the Biotechnology Industry Association in Hong Kong. Dr Lee is also a member of the Institute of Directors